|
000
| 01540nam 2200349zi 4500 |
|---|
| 001 | 9.872231 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107163610 |
|---|
| 006 | m go d f |
|---|
| 007 | cr |n |||||||| |
|---|
| 008 | 190430s2017 onc #o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 041 | |aeng|afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-34/2017-PDF |
|---|
| 245 | 00|aPotential savings from biosimilars in Canada = |bÉconomies potentielles associées aux biosimilaires au Canada. |
|---|
| 246 | 11|aÉconomies potentielles associées aux biosimilaires au Canada |
|---|
| 264 | 1|a[Ottawa] : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2017] |
|---|
| 300 | |a1 online resource (1 page) : |bcoloured graphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |a"NPDUIS. National Prescription Drug Utilization Information System. Supporting health care decision making in Canada." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references. |
|---|
| 546 | |aText in English and in French. |
|---|
| 692 | 07|2gccst|aPrescription drugs |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board. |
|---|
| 792 | |tPotential savings from biosimilars in Canada = |w(CaOODSP)9.872233 |
|---|
| 856 | 40|qPDF|uhttps://publications.gc.ca/collections/collection_2019/cepmb-pmprb/H82-34-2017.pdf|s441 KB |
|---|
| 856 | 4 |qHTML|sN/A|uhttp://www.pmprb-cepmb.gc.ca/view.asp?ccid=1304&lang=en |
|---|